The findings of this meta-analysis suggest that specific targeted therapy for Mycobacterium abscessus subspecies abscessus can improve treatment outcomes, and may help to design future antimicrobial drug regimens in this difficult to treat lung infection
The physiological factors that contribute to Mycobacterium abscessus lung infections remain unclear....
Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effe...
Mycobacterium abscessus is the most drug-resistant mycobac-terial species (1, 2). Combination therap...
The findings of this meta-analysis suggest that specific targeted therapy for Mycobacterium abscessu...
Treatment of Mycobacterium abscessus pulmonary disease (MAB-PD), caused by M. abscessus subsp. absce...
Background. Mycobacterium abscessus can produce a chronic pulmonary infection for which little is kn...
Background: The contemporary guidelines have recommended multiple antimicrobial therapies along with...
BACKGROUND: Treatment outcomes of patients with Mycobacterium abscessus subspecies abscessus lung di...
Pulmonary disease due to Mycobacterium abscessus (Mab) has become an increasing cause of health conc...
Descriptor Number: 127. Non-tuberculous mycobacterial disease: clinical aspects Word count (excludin...
A patient with Mycobacterium abscessus lung disease was mistaken to have pulmonary tuberculosis with...
SummaryBackgroundMycobacterium abscessus complex is the second most common organism isolated from pa...
SummaryBackgroundThe ATS (American Thoracic Society) has recommended periodic administration of mult...
Mycobacterium abscessus complex is the most virulent of rapidly growing mycobacteria causing invasiv...
Mycobacteria are a large family of over 100 species, most of which do not cause diseases in humans. ...
The physiological factors that contribute to Mycobacterium abscessus lung infections remain unclear....
Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effe...
Mycobacterium abscessus is the most drug-resistant mycobac-terial species (1, 2). Combination therap...
The findings of this meta-analysis suggest that specific targeted therapy for Mycobacterium abscessu...
Treatment of Mycobacterium abscessus pulmonary disease (MAB-PD), caused by M. abscessus subsp. absce...
Background. Mycobacterium abscessus can produce a chronic pulmonary infection for which little is kn...
Background: The contemporary guidelines have recommended multiple antimicrobial therapies along with...
BACKGROUND: Treatment outcomes of patients with Mycobacterium abscessus subspecies abscessus lung di...
Pulmonary disease due to Mycobacterium abscessus (Mab) has become an increasing cause of health conc...
Descriptor Number: 127. Non-tuberculous mycobacterial disease: clinical aspects Word count (excludin...
A patient with Mycobacterium abscessus lung disease was mistaken to have pulmonary tuberculosis with...
SummaryBackgroundMycobacterium abscessus complex is the second most common organism isolated from pa...
SummaryBackgroundThe ATS (American Thoracic Society) has recommended periodic administration of mult...
Mycobacterium abscessus complex is the most virulent of rapidly growing mycobacteria causing invasiv...
Mycobacteria are a large family of over 100 species, most of which do not cause diseases in humans. ...
The physiological factors that contribute to Mycobacterium abscessus lung infections remain unclear....
Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effe...
Mycobacterium abscessus is the most drug-resistant mycobac-terial species (1, 2). Combination therap...
DOI
Add to ORKG